Physician profile
Jong J Choi
NPI 1295845584
$2,340.75
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,115 · 2020: $490 · 2021: $680 · 2022: $55.79.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,075.55 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $514.58 | 2019-2021 | |
| Daiichi Sankyo INC. | $204.41 | 2019 | |
| Pfizer INC. | $176.45 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $101.37 | 2019 | |
| Biodelivery Sciences International, INC. | $97.36 | 2019-2021 | |
| Redhill Biopharma INC. | $75.61 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $56.72 | 2019 | |
| Assertio Therapeutics, INC. | $13.64 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.83 | 2019 | |
| Mdd US Operations, LLC | $12.23 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jong Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.